Carol Karp
Conseiller Juridique Général chez PROTHENA CORPORATION PLC
Fortune : - $ au 30/04/2024
Profil
Carol D.
Karp is currently the Vice Chairman-Trustees Board at Rochester Christian University and the Chief Regulatory Officer at Prothena Corp.
Plc.
Previously, she held positions such as Officer at VIVUS, Inc., SVP-Regulatory Affairs, Quality & Drug Safety at CV Therapeutics, Inc., Senior VP-Regulatory Affairs & Compliance at Esperion Therapeutics, Inc., Vice President-Scientific Affairs at Powderject Technologies BV, and Vice President & Head-Global Regulatory Affairs at Janssen Alzheimer Immunotherapy.
Ms. Karp obtained her undergraduate degree from Rochester Christian University and New York University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROTHENA CORP. PLC
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Carol Karp
| Sociétés | Poste | Début |
|---|---|---|
| PROTHENA CORPORATION PLC | Conseiller Juridique Général | 15/12/2016 |
| Rochester Christian University | Directeur/Membre du Conseil | - |
Anciens postes connus de Carol Karp
| Sociétés | Poste | Fin |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Compliance Officer | 01/01/2014 |
| Janssen Alzheimer Immunotherapy | Conseiller Juridique Général | 01/01/2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Conseiller Juridique Général | 02/05/2011 |
| VIVUS, INC. | Corporate Officer/Principal | - |
| Powderject Technologies BV | Directeur Technique/Scientifique/R&D | - |
Formation de Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
| Janssen Alzheimer Immunotherapy |
